Premium
Exogenous Lipid Clearance in Compensated Liver Cirrhosis
Author(s) -
Muscaritoli Maurizio,
Cangiano Carlo,
Cascino Antonia,
Ceci Fabrizio,
Caputo Velia,
Martino Piero,
Serra Pietro,
Rossi Fanelli Filippo
Publication year - 1986
Publication title -
journal of parenteral and enteral nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.935
H-Index - 98
eISSN - 1941-2444
pISSN - 0148-6071
DOI - 10.1177/0148607186010006599
Subject(s) - cirrhosis , medicine , endocrinology , triglyceride , endogeny , liver disease , pathogenesis , hepatic encephalopathy , chemistry , gastroenterology , cholesterol
The tolerance to exogenous fats has been evaluated in patients with liver cirrhosis. A three‐stage lipid clearance test with continuous infusion (3 hr) of a triglyceride emulsion, Intralipid, was performed on 10 patients with well compensated liver cirrhosis and 10 normolipidemic volunteers. During the infusion, blood samples were collected for the measurement of particulate triglycerides (TG) by nephelometry; samples were also collected for total TG, free fatty acids (FFA) and free trytophan (TRP) determinations. Plasma endogenous triglycerides were calculated as the total minus exogenous, particulate, TG. The fractional removal rate (K2) and the maximal clearing capacity (K1) for exogenous TG were lower in patients than in controls, though a significant difference (p < 0.05) was found only for K1. Endogenous TG and FFA showed a comparable rise in patients and controls during Intralipid infusion. A significant increase in free TRP was noted in cirrhotics upon maximal infusion rate. It is concluded that: 1) in patients with well compensated liver cirrhosis the maximal clearing capacity (K1) for exogenous TG is impaired. Nonetheless, moderate amounts of fat may be removed at a normal rate from the bloodstream; 2) a normal synthesis rate of exogenous TG may be maintained even in a severely damaged liver; 3) considering the possible role of free TRP in the pathogenesis of hepatic encephalopathy (HE), the use of large amounts of lipids should be discouraged in patients with decompensated liver cirrhosis, or even avoided in those with impending or overt HE. (Journal of Parenteral and Enteral Nutrition 10:599–603, 1986)